The NemaMetrix ScreenChip platform technology was recognized by the White House as one of the breakthrough life science research technologies. CEO Matt Beaudet spoke with Dr. Robbie Barbero of the US White House Office of Science and Technology Policy, who created a post on the White House website about the promise of new research technologies.
NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards commercialization.
NemaMetrix announces being awarded $188,000 for a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health. The funds will be used to support fundamental proof of concept research, with an eye towards near-term commercialization, of a microfluidic screening device for health-span extending drugs.